What is NDC 68382-110?

68382-110 is the product NDC for Bromocriptine mesylate, Bromocriptine mesylate 5 mg/1 capsule, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bromocriptine mesylate?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bromocriptine mesylate NDC 68382-110

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68382-110-01	6838201100168382011001	100 CAPSULE in 1 BOTTLE (68382-110-01)Marketed from Jan 23, 2009
68382-110-06	6838201100668382011006	30 CAPSULE in 1 BOTTLE (68382-110-06)Marketed from Jan 23, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bromocriptine mesylate
Generic name (nonproprietary): bromocriptine mesylate
Active ingredients: Bromocriptine mesylate — 5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 68382
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078899
Marketing start: Jan 23, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Ergolines (Chemical structure)
Identifiers: Product ID 68382-110_98e43e82-81ff-465b-a27d-f620b182705cSPL ID 98e43e82-81ff-465b-a27d-f620b182705cSPL set ID d69003ee-0b6f-47a9-834e-ba59c02f566cRxCUI 197412UNII FFP983J3ODUPC 0368382110015
Pharmacologic class: Ergot Derivative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382011001 followed by a unit qualifier and the quantity

Package 68382-0110-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

Bromocriptine mesylate is an ergot derivative indicated for the treatment of: Hyperprolactinemia-associated dysfunction including amenorrhea with or without galactorrhea, infertility, or hypogonadism in adults ( 1.1 ) Prolactin-secreting adenomas in adults and pediatric patients 11 years of age and older ( 1.2 ). Acromegaly in adults ( 1.3 ). Signs and symptoms of idiopathic Parkinson's disease or postencephalitic parkinsonism in adults ( 1.4 ). Limitations of Use Avoid use of bromocriptine mesylate capsule for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions ( 1.1 , 5.4 ) 1.1 Hyperprolactinemia-Associated Dysfunction Bromocri…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68382-110

What is NDC 68382-110?: 68382-110 is the product NDC for Bromocriptine mesylate, Bromocriptine mesylate 5 mg/1 capsule, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bromocriptine mesylate.
What is the active ingredient?: Bromocriptine mesylate.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bromocriptine mesylate?: 8 other product NDCs are listed under this name. See all Bromocriptine mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bromocriptine mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bromocriptine Mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	American Health Packaging	60687-931	60687-0931-21
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4628	70518-4628-00
Bromocriptine Mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-951	70954-0951-1070954-0951-20
Bromocriptine Mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-978	70954-0978-1070954-0978-20
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	Padagis US LLC	0574-0106	00574-0106-0100574-0106-03
Bromocriptine Mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Mylan Pharmaceuticals Inc.	0378-7096	00378-7096-0100378-7096-93
Bromocriptine mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Zydus Lifesciences Limited	65841-654	65841-0654-0165841-0654-06
Bromocriptine mesylate	Bromocriptine mesylate 2.5 mg/1	TabletOral	Sandoz Inc	0781-5325	00781-5325-0100781-5325-31

Other NDCs under ANDA 078899

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078899
Product	Strength	Form · route	Labeler	Product NDC
Bromocriptine mesylate	Bromocriptine mesylate 5 mg/1	CapsuleOral	Zydus Lifesciences Limited	65841-654